Results 231 to 240 of about 136,951 (330)

Potential therapeutic effects of peroxisome proliferator-activated receptors on corneal diseases. [PDF]

Exp Biol Med (Maywood)
Chow BJ, Lee IXY, Liu C, Liu YC.
europepmc   +1 more source

Outcome parameters in studies investigating dry eye disease: A systematic literature review

Acta Ophthalmologica, EarlyView.
Abstract The development of effective therapeutics for dry eye disease (DED) is challenging due to its complex pathophysiology, heterogeneous patient presentation and the significant failure rate of previous clinical development programs. This underlines the importance of the selection of appropriate endpoints for clinical trials.
Viktoria Pai, Doreen Schmidl, Liudmyla Petric, Patrick Janku, Theresa Lindner, Ulrich Graf, Jacqueline Chua, Leopold Schmetterer, Gerhard Garhöfer   +8 more
wiley   +1 more source

Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases. [PDF]

Pharmaceutics, 2020
Bastola P, Song L, Gilger BC, Hirsch ML.
europepmc   +1 more source

Association Between Central Corneal Thickness and Disease Severity in Primary Open-Angle Glaucoma

Kathak Das, Syeda Fahmida Farzana Aziz, Prakash Kumar Chowdhury, Md Altaf Uddin Khan, Pradipta Narayan Chowdhury   +4 more
openalex   +2 more sources

Anterior chamber flare and central macular thickness after trabeculectomy versus after phacoemulsification

Acta Ophthalmologica, EarlyView.
Abstract Purpose To compare the inflammatory response in the eye after trabeculectomy to after phacoemulsification, focusing on anterior chamber flare (AC flare) and central macular thickness (CMT). Methods Data from 436 participants in two randomized controlled trials were analysed.
Yasmeen Ahmed, Jesper Høiberg Erichsen, Afrouz Ahmadzadeh, Lars Morten Holm, Line Kessel, Daniella Bach‐Holm   +5 more
wiley   +1 more source

Deep learning model for extensive smartphone-based diagnosis and triage of cataracts and multiple corneal diseases. [PDF]

Br J Ophthalmol
Ueno Y, Oda M, Yamaguchi T, Fukuoka H, Nejima R, Kitaguchi Y, Miyake M, Akiyama M, Miyata K, Kashiwagi K, Maeda N, Shimazaki J, Noma H, Mori K, Oshika T.   +14 more
europepmc   +1 more source

Deep learning for identifying corneal diseases from ocular surface slit-lamp photographs. [PDF]

Sci Rep, 2020
Gu H, Guo Y, Gu L, Wei A, Xie S, Ye Z, Xu J, Zhou X, Lu Y, Liu X, Hong J.   +10 more
europepmc   +1 more source

‘Pulsed’ immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease [PDF]

, 1987
P Meyer, Peter Watson, W. Franks, Paul Dubord   +3 more
openalex   +1 more source

Using continuous visual stimulus tracking for detecting visual function loss due to acquired brain injury

Acta Ophthalmologica, EarlyView.
Abstract Purpose Acquired brain injury (ABI) may cause homonymous visual field (VF) defects. Standard automated perimetry (SAP) is the gold standard for VF assessment, but it can be challenging in ABI. Continuous visual stimulus tracking (SONDA; Standardised Oculomotor and Neurological Disorders Assessment) simplifies the perimetric task to following a
A. C. L. Vrijling, M. J. de Boer, R. J. Renken, J. B. C. Marsman, J. Heutink, F. W. Cornelissen, N. M. Jansonius   +6 more
wiley   +1 more source

The application of high-throughput sequencing technology in corneal diseases. [PDF]

Int Ophthalmol
Zhao JY, He YX, Wu ML, Wang RQ.
europepmc   +1 more source